Treatment options for sickle cell disease and other childhood blood disorders have improved dramatically in the last decade. Much of that progress is due to clinical trials and research. WashU Medicine researchers at St. Louis Children’s Hospital are leaders in developing new therapies for children.
Advancing blood disorder research
Our team of WashU Medicine physicians continuously seeks new ways to help children with blood disorders through clinical trials for sickle cell disease, lymphoma, and other conditions.
We participate in clinical trials through the National Institutes of Health (NIH) Children's Oncology Group (COG), and in studies sponsored by pharmaceutical companies.
For example, silent strokes—strokes that do not have outward symptoms—are more common in children with blood disorders. These strokes can cause problems with memory and learning. Our research examines blood flow patterns in these patients in the hopes of finding new treatments for the future.
Find a pediatric blood disorder clinical trial
All open non-malignant (hematology) clinical trials available at St. Louis Children’s Hospital are listed on the Siteman Cancer Center website.
To learn more, call St. Louis Children's Hospital at 314-454-5437.
